{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Wittman%20Pharma%2C%20Inc.","name":"Wittman Pharma, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T05:55:42.378Z"},"count":1,"matches":[{"id":"c29c7c8e9a60f7f2","posted_date":"2024-09-24","letter_issue_date":"2024-08-06","company_name":"Wittman Pharma, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations II","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/c29c7c8e9a60f7f2"}]}